Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Bayer, Belite Bio, Cullinan, Intrabio, Lupin, Galvanize, Portal Access, Sunrise.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord Biopharma, Acist, Astrazeneca, Boehringer Ingelheim, Daiichi, Genentech, GSK, H. Lundbeck, Krystal, Natera, Vertanical, Viatris.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Fujirebio, Gyre, H.U. Group, Innovent, Kyowa Kirin, Shionogi, Taiho, Taiho Oncology, Viiv Healthcare, Zai Lab, Zhejiang Wenda.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Sandoz, Valar Labs.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alloplex, Beone, Clearpoint, Glooko, Inmune, Kyowa Kirin, Taiho, Taiho Oncology.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cepheid, Epineuron, Femasys, Gyre, Kyverna, Pfizer, Revvity, Siemens.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Bayesian, Coya, Eli Lilly, Roche.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apyx, Argenx, Biozen, Corvention, Fujirebio, H.U. Group Holdings, Innovent, Partner, Shionogi, Sironax, Transpire, Viiv, Zai Lab, Zhejiang Wenda.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, Chance, Eisai, Kelun-Biotech, Lanexa, Mezzion, Norgine, Rznomics, Specialised, Sunshine Lake, Ultragreen.ai.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, BMS, Chance, Eisai, Kelun-Biotech, Mezzion, Rivanna, Rznomics.